{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:51:18Z","timestamp":1787946678557,"version":"build-2784847793"},"reference-count":29,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[1998,1,1]],"date-time":"1998-01-01T00:00:00Z","timestamp":883612800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2001,12,25]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We have measured by flow cytometry the ability of subsets of CD8+\u2003CD3+ lymphocytes within mononuclear cell preparations to make intracellular cytokines (IL-2, tumour necrosis factor-alpha (TNF-\u03b1) and IFN-\u03b3) on stimulation in vitro with phorbol myristate acetate (PMA) and ionomycin for 16\u2003h. These CD8+ subsets were defined by the presence or absence of CD28 or HLA-DR. Subsets of normal CD8+ cells were compared with cells from the antibody deficiency disease common variable immunodeficiency (CVID). In CVID there was a significant increase in the production of IFN-\u03b3 in the CD8+\u2003CD28+ subset (\u2018cytotoxic\u2019). This reflects a shift in this disease towards an excessive Th1 response away from B cell help. Paradoxically, some CVID patients also showed a reduction in IFN-\u03b3 production in the CD8+\u2003CD28\u2212 subset (\u2018suppressor\u2019) which was associated with a failure of these cells to maintain a state of activation after a stimulus in vitro. The B cell problem in this disease is known to be related to a failure of T cell help shown by an inability to produce the antigen-specific CD4+ memory T cells needed for successful B cell maturation. The two pathological CD28 subsets of CD8+ cells we have found in CVID may both be detrimental to a normal CD4-dependent immune response. The CD28\u2212 suppressor subset expands and is unable to maintain activation and cytokine secretion, and the CD28+ cytotoxic subset is over-producing the Th1 cytokine IFN-\u03b3.<\/jats:p>","DOI":"10.1046\/j.1365-2249.1998.00479.x","type":"journal-article","created":{"date-parts":[[2003,3,11]],"date-time":"2003-03-11T10:08:12Z","timestamp":1047377292000},"page":"70-75","source":"Crossref","is-referenced-by-count":60,"title":["Primary defect in CD8+ lymphocytes in the antibody deficiency disease (common variable immunodeficiency): abnormalities in intracellular production of interferon-gamma (IFN-\u03b3) in CD28+ (\u2018cytotoxic\u2019) and CD28\u2212 (\u2018suppressor\u2019) CD8+ subsets"],"prefix":"10.1093","volume":"111","author":[{"given":"M E","family":"North","sequence":"first","affiliation":[{"name":"MRC Immunodeficiency Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D B","family":"Webster","sequence":"additional","affiliation":[{"name":"MRC Immunodeficiency Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Farrant","sequence":"additional","affiliation":[{"name":"MRC Immunodeficiency Group, Department of Clinical Immunology, Royal Free Hospital School of Medicine, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2001,12,25]]},"reference":[{"key":"b1_382","first-page":"1","volume":"99","author":"WHO Scientific Group","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"b2_383","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1997.d01-993.x"},{"key":"b3_384","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.11.1.49"},{"key":"b4_385","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(74)91940-0"},{"key":"b5_386","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/j.1365-2249.1994.tb06511.x","volume":"95","author":"North ME","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"b6_387","first-page":"1194","volume":"6","author":"Saukkonen JJ","year":"1993","journal-title":"J AIDS"},{"key":"b7_388","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/0008-8749(82)90289-1","volume":"72","author":"Lum LG","year":"1982","journal-title":"Cell Immunol"},{"key":"b8_389","doi-asserted-by":"crossref","first-page":"32","DOI":"10.4049\/jimmunol.144.1.32","volume":"144","author":"Koide J","year":"1990","journal-title":"J Immunol"},{"key":"b9_390","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/0090-1229(91)90068-L","volume":"60","author":"Freedman MS","year":"1991","journal-title":"Clin Immunol Immunopathol"},{"key":"b10_391","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.4049\/jimmunol.150.4.1147","volume":"150","author":"Azuma M","year":"1993","journal-title":"J Immunol"},{"key":"b11_392","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1002\/eji.1830200613","volume":"20","author":"Li SG","year":"1990","journal-title":"Eur J Immunol"},{"key":"b12_393","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.immunol.12.1.227"},{"key":"b13_394","first-page":"299","volume":"70","author":"Del Prete G","year":"1994","journal-title":"Lab Invest"},{"key":"b14_395","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1600-065X.1991.tb00578.x","volume":"119","author":"Sander B","year":"1991","journal-title":"Immunol Rev"},{"key":"b15_396","doi-asserted-by":"publisher","DOI":"10.1016\/0022-1759(93)90158-4"},{"key":"b16_397","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.d01-795.x"},{"key":"b17_398","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2249.1991.tb05805.x","volume":"86","author":"North ME","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"b18_399","first-page":"122","volume":"4","author":"Inoue Y","year":"1994","journal-title":"Clin Immunol"},{"key":"b19_400","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1126\/science.8023142","volume":"265","author":"Maggi E","year":"1994","journal-title":"Science"},{"key":"b20_401","doi-asserted-by":"crossref","first-page":"6174","DOI":"10.4049\/jimmunol.154.11.6174","volume":"154","author":"Lester MR","year":"1995","journal-title":"J Immunol"},{"key":"b21_402","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.4049\/jimmunol.154.9.4623","volume":"154","author":"Ghalib HW","year":"1995","journal-title":"J Immunol"},{"key":"b22_403","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1111\/j.1365-2249.1994.tb05503.x","volume":"98","author":"Chensue SW","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"b23_404","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1172\/JCI117611","volume":"94","author":"Zhang M","year":"1994","journal-title":"J Clin Invest"},{"key":"b24_405","first-page":"7","volume":"5","author":"Romagnani S","year":"1994","journal-title":"European Cytokine Network"},{"key":"b25_406","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1128\/CDLI.2.2.249-252.1995","volume":"2","author":"Crucian B","year":"1995","journal-title":"Clin Diagn Lab Immunol"},{"key":"b26_407","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1002\/art.1780380512","volume":"38","author":"Sfikakis PP","year":"1995","journal-title":"Arthritis Rheum"},{"key":"b27_408","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1111\/j.1365-2249.1995.tb03717.x","volume":"100","author":"Vingerhoets JH","year":"1995","journal-title":"Clin Exp Immunol"},{"key":"b28_409","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2249.1996.d01-746.x"},{"key":"b29_410","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.4049\/jimmunol.137.4.1194","volume":"137","author":"Hoxie JA","year":"1986","journal-title":"J Immunol"}],"container-title":["Clinical and Experimental Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.1998.00479.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2249.1998.00479.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/111\/1\/70\/42205808\/j.1365-2249.1998.00479.x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cei\/article-pdf\/111\/1\/70\/42205808\/j.1365-2249.1998.00479.x.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,9]],"date-time":"2024-01-09T07:37:44Z","timestamp":1704785864000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cei\/article\/111\/1\/70\/6483209"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":29,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2001,12,25]]},"published-print":{"date-parts":[[2001,12,25]]}},"URL":"https:\/\/doi.org\/10.1046\/j.1365-2249.1998.00479.x","relation":{},"ISSN":["0009-9104","1365-2249"],"issn-type":[{"value":"0009-9104","type":"print"},{"value":"1365-2249","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[1998,1]]},"published":{"date-parts":[[1998,1]]}}}